Mumtaz Anwar, PhD, is currently a Postdoctoral Research Scientist at the Department of Pharmacology and Regenerative Medicine, College of Medicine, University of Illinois at Chicago, Illinois, USA. Dr Anwar obtained his PhD in Cancer Biology and Molecular Epigenetics at the Faculty of Medicine, department of Gastroenterology and department of Experimental Medicine and Biotechnology, PGIMER, Chandigarh, India. His PhD thesis concerned the investigation of Wnt signaling pathway in search for new tumor prognostic and biomarkers in colorectal cancer. Dr Anwar is the author of many book chapters and journal articles about tumor markers and is involved in other scientific activities in this advanced molecular technology era. He is a member of various Scientific Organizations and societies including American Heart Association (AHA), American Society for Pharmacology and Experimental Therapeutics (ASPET), ASPET Young Scientists Committee, North American Vascular Biology Organization (NAVBO), United States and Canadian Academy of Pathology (USCAP). He is the recipient of various awards including Outstanding Young Investigator Travel Award and other Postdoctoral competition category awards. He is also an editorial board member and reviewer and reviews research articles to various scientific journals.